Screener by Innerkore

Innova Captab Limited

NSE: INNOVACAPBSE: 544067HealthcarePharmaceuticals & Biotechnology

Innova Captab Limited is an Indian listed company in the Pharmaceuticals & Biotechnology industry (Healthcare sector), traded under NSE: INNOVACAP and BSE: 544067 (ISIN INE0DUT01020).

It has a market capitalisation of ₹5,732 crore, a last close of ₹1,002 on 2026-10-19, a one-year return of 23.9%.

Valuation: a price-to-earnings ratio of 36.68x, a price-to-book ratio of 5.30x, a dividend yield of 0.2%.

Profitability: return on equity of 0.0%, return on capital employed of 16.0%, an operating margin of 14.8%.

Balance sheet and ownership: debt-to-equity of 0.32x, promoter holding of 50.9%.

Key figures for INNOVACAP, prices as of 2026-10-19
MetricValue
Market capitalisation5,732
Last close₹1,002
P/E (TTM)36.68x
P/B5.30x
Dividend yield0.2%
ROE (FY)0.0%
ROCE (FY)16.0%
Operating margin (TTM)14.8%
Debt / equity0.32x
Promoter holding50.9%
1-year return23.9%

Loading the live page with the price chart, financial history, shareholding and recent filings. Data is end-of-day and rebuilt nightly; nothing here is investment advice. Financial statements · What each metric means